Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1807503-86-1
1951439-46-5
252378-69-1
1235514-18-7
1895922-75-4
1895922-74-3
262862-70-4 | 4-(4-Chlorophenoxy)benzaldehyde oxime | AA00I4XG | MFCD09706784
2746-19-2 | Cis-5-norbornene-exo-2,3-dicarboxylic anhydride | AA00I54H | MFCD00630580
2901-75-9 | N-Acetyl-DL-phenylalanine | AA00I5BG | MFCD00063157
30189-36-7 | Boc-Lys(Boc)-OSu | AA00I5L6 | MFCD00057898
314766-04-6 | 4-Hydrazino-4-oxo-n-phenylbutanamide | AA00I5VO | MFCD01990161
32289-58-0 | Poly(iminocarbonimidoyliminocarbonimidoylimino-1,6-hexanediyl),hydrochloride | AA00I61P | MFCD00217750
3289-50-7 | 4-Amino-2,6-dimethoxypyrimidine | AA00I67R | MFCD00082802
334981-10-1 | 4-(Pyrrolidine-1-sulfonylmethyl)aniline | AA00I6IO | MFCD06795500
3430-16-8 | 3-Bromo-5-methylpyridine | AA00I6P5 | MFCD01646141
35132-20-8 | (1R,2R)-(+)-1,2-Diphenylethylenediamine | AA00I6VS | MFCD00082769